Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

472 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Alternating chemotherapy with etoposide plus cisplatin and topotecan plus paclitaxel in patients with untreated, extensive-stage small cell lung carcinoma: a phase II trial of the North Central Cancer Treatment Group.
Jett JR, Hatfield AK, Hillman S, Bauman MD, Mailliard JA, Kugler JW, Morton RF, Marks RS, Levitt R. Jett JR, et al. Among authors: levitt r. Cancer. 2003 May 15;97(10):2498-503. doi: 10.1002/cncr.11377. Cancer. 2003. PMID: 12733149 Free article. Clinical Trial.
Evaluation of shark cartilage in patients with advanced cancer: a North Central Cancer Treatment Group trial.
Loprinzi CL, Levitt R, Barton DL, Sloan JA, Atherton PJ, Smith DJ, Dakhil SR, Moore DF Jr, Krook JE, Rowland KM Jr, Mazurczak MA, Berg AR, Kim GP; North Central Cancer Treatment Group. Loprinzi CL, et al. Among authors: levitt r. Cancer. 2005 Jul 1;104(1):176-82. doi: 10.1002/cncr.21107. Cancer. 2005. PMID: 15912493 Free article. Clinical Trial.
Long-term survival of patients with advanced/recurrent carcinoma of cervix and vagina after neoadjuvant treatment with methotrexate, vinblastine, doxorubicin, and cisplatin with or without the addition of molgramostim, and review of the literature.
Long HJ 3rd, Rayson S, Podratz KC, Abu-Ghazaleh S, Suman V, Hartmann LC, Levitt R, Nair S, Hatfield AK, Knost JA. Long HJ 3rd, et al. Among authors: levitt r. Am J Clin Oncol. 2002 Dec;25(6):547-51. doi: 10.1097/00000421-200212000-00002. Am J Clin Oncol. 2002. PMID: 12477995 Clinical Trial.
Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma.
Bonner JA, Sloan JA, Shanahan TG, Brooks BJ, Marks RS, Krook JE, Gerstner JB, Maksymiuk A, Levitt R, Mailliard JA, Tazelaar HD, Hillman S, Jett JR. Bonner JA, et al. Among authors: levitt r. J Clin Oncol. 1999 Sep;17(9):2681-91. doi: 10.1200/JCO.1999.17.9.2681. J Clin Oncol. 1999. PMID: 10561342 Clinical Trial.
A phase II study of sequential combination chemotherapy with cyclophosphamide, prednisone, and 2-chlorodeoxyadenosine in previously untreated patients with chronic lymphocytic leukemia.
Tefferi A, Li CY, Reeder CB, Geyer SM, Allmer C, Levitt R, Michalak JC, Addo F, Krook JE, Witzig TE, Schaefer PL, Mailliard JA. Tefferi A, et al. Among authors: levitt r. Leukemia. 2001 Aug;15(8):1171-5. doi: 10.1038/sj.leu.2402172. Leukemia. 2001. PMID: 11480558 Clinical Trial.
Comparison of conventional dose and double dose carboplatin in patients receiving cyclophosphamide plus carboplatin for advanced ovarian carcinoma: a North Central Cancer Treatment Group Study.
Edmonson JH, Suman VJ, Dalton RJ, Bro WC, Gallenberg MM, Long HJ, Levitt R, Hatfield AK, Krook JE, Mailliard JA, Gerstner JB; North Central Cancer Treatment Group. Edmonson JH, et al. Among authors: levitt r. Cancer Invest. 2001;19(6):597-602. doi: 10.1081/cnv-100104287. Cancer Invest. 2001. PMID: 11486702 Clinical Trial.
472 results